Advertisement
Review Article| Volume 2, ISSUE 1, P81-97, May 2022

Geriatric Assessments

Tools for Every Oncologist to Stage the Aging When Caring for Older Adults with Cancer

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. He W, Goodkind D, Kowal P. Census Bureau, International Population Reports, P95/16-1, An Aging World: 2015.

      2. Older People Projected to Outnumber Children for First Time in U.S. History. In; National Population Projections, 2017. www.census.gov/programs-surveys/popproj.html. March 13, 2018.

        • Smith B.D.
        • Smith G.L.
        • Hurria A.
        • et al.
        Future of cancer incidence in the United States: burdens upon an aging, changing nation.
        J Clin Oncol. 2009; 27: 2758-2765
        • Chaïbi P.
        • Magné N.
        • Breton S.
        • et al.
        Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients.
        Crit Rev Oncol Hematol. 2011; 79: 302-307
        • Williams G.R.
        • Weaver K.E.
        • Lesser G.J.
        • et al.
        Capacity to provide geriatric specialty care for older adults in community oncology practices.
        Oncologist. 2020; 25: 1032-1038
        • Dotan E.
        • Walter L.C.
        • Browner I.S.
        • et al.
        NCCN Guidelines® Insights: Older Adult Oncology, Version 1..
        Journal of the National Comprehensive Cancer Network. 2021; 19: 1006-1019
        • Mohile S.G.
        • Dale W.
        • Somerfield M.R.
        • et al.
        Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology.
        J Clin Oncol. 2018; 36: 2326-2347
        • Maione P.
        • Perrone F.
        • Gallo C.
        • et al.
        Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.
        J Clin Oncol. 2005; 23: 6865-6872
        • Koroukian S.M.
        • Xu F.
        • Bakaki P.M.
        • et al.
        Comorbidities, functional limitations, and geriatric syndromes in relation to treatment and survival patterns among elders with colorectal cancer.
        J Gerontol A Biol Sci Med Sci. 2010; 65: 322-329
        • Winkelmann N.
        • Petersen I.
        • Kiehntopf M.
        • et al.
        Results of comprehensive geriatric assessment effect survival in patients with malignant lymphoma.
        J Cancer Res Clin Oncol. 2011; 137: 733-738
        • Studenski S.
        • Perera S.
        • Patel K.
        • et al.
        Gait speed and survival in older adults.
        JAMA. 2011; 305: 50-58
        • White D.K.
        • Neogi T.
        • Nevitt M.C.
        • et al.
        Trajectories of gait speed predict mortality in well-functioning older adults: the health, aging and body composition study.
        J Gerontol A Biol Sci Med Sci. 2013; 68: 456-464
        • Klepin H.D.
        • Geiger A.M.
        • Tooze J.A.
        • et al.
        Physical performance and subsequent disability and survival in older adults with malignancy: results from the health, aging and body composition study.
        J Am Geriatr Soc. 2010; 58: 76-82
        • Schmidt K.
        • Vogt L.
        • Thiel C.
        • et al.
        Validity of the six-minute walk test in cancer patients.
        Int J Sports Med. 2013; 34: 631-636
        • Kasymjanova G.
        • Correa J.A.
        • Kreisman H.
        • et al.
        Prognostic value of the six-minute walk in advanced non-small cell lung cancer.
        J Thorac Oncol. 2009; 4: 602-607
        • Mathias S.
        • Nayak U.S.
        • Isaacs B.
        Balance in elderly patients: the "get-up and go" test.
        Arch Phys Med Rehabil. 1986; 67: 387-389
        • Shumway-Cook A.
        • Brauer S.
        • Woollacott M.
        Predicting the probability for falls in community-dwelling older adults using the timed up & go test.
        Phys Ther. 2000; 80: 896-903
        • Nakano J.
        • Fukushima T.
        • Tanaka T.
        • et al.
        Physical function predicts mortality in patients with cancer: a systematic review and meta-analysis of observational studies.
        Support Care Cancer. 2021; 29: 5623-5634
        • Guralnik J.M.
        • Simonsick E.M.
        • Ferrucci L.
        • et al.
        A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission.
        J Gerontol. 1994; 49: M85-M94
        • Liuu E.
        • Saulnier P.J.
        • Gand E.
        • et al.
        Frailty and diabetes status in older patients with cancer: impact on mortality in the ANCRAGE cohort.
        Aging Clin Exp Res. 2020; 32: 1809-1819
        • Meyerhardt J.A.
        • Catalano P.J.
        • Haller D.G.
        • et al.
        Impact of diabetes mellitus on outcomes in patients with colon cancer.
        J Clin Oncol. 2003; 21: 433-440
        • Nanda A.
        • Chen M.H.
        • Braccioforte M.H.
        • et al.
        Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction.
        JAMA. 2009; 302: 866-873
        • Charlson M.E.
        • Pompei P.
        • Ales K.L.
        • et al.
        A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
        J Chronic Dis. 1987; 40: 373-383
        • Linn B.S.
        • Linn M.W.
        • Gurel L.
        Cumulative illness rating scale.
        J Am Geriatr Soc. 1968; 16: 622-626
        • Fillenbaum G.G.
        • Smyer M.A.
        The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire.
        J Gerontol. 1981; 36: 428-434
        • VANH H.K.
        • Vreugdenhil G.
        Age adjusted charlson comorbidity index strongly influences survival, irrespective of performance status and age, in patients with advanced prostatic cancer treated with enzalutamide.
        Anticancer Res. 2019; 39: 863-866
        • Frasci G.
        • Lorusso V.
        • Panza N.
        • et al.
        Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer.
        J Clin Oncol. 2000; 18: 2529-2536
        • Sanabria A.
        • Carvalho A.L.
        • Vartanian J.G.
        • et al.
        Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
        Ann Surg Oncol. 2007; 14: 1449-1457
        • Gronberg B.H.
        • Sundstrom S.
        • Kaasa S.
        • et al.
        Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy.
        Eur J Cancer. 2010; 46: 2225-2234
        • Katsoulis M.
        • Kyrozis A.
        • Trichopoulou A.
        • et al.
        Cognitive impairment and cancer mortality: a biological or health care explanation?.
        Cancer Causes Control. 2014; 25: 1565-1570
        • Stilley C.S.
        • Bender C.M.
        • Dunbar-Jacob J.
        • et al.
        The impact of cognitive function on medication management: three studies.
        Health Psychol. 2010; 29: 50-55
        • Ahles T.A.
        • Saykin A.J.
        • McDonald B.C.
        • et al.
        Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.
        J Clin Oncol. 2010; 28: 4434-4440
        • Extermann M.
        • Boler I.
        • Reich R.R.
        • et al.
        Predicting the risk of chemotherapy toxicity in older patients: the chemotherapy risk assessment scale for high-age Patients (CRASH) score.
        Cancer. 2012; 118: 3377-3386
        • Borson S.
        • Scanlan J.M.
        • Chen P.
        • et al.
        The Mini-Cog as a screen for dementia: validation in a population-based sample.
        J Am Geriatr Soc. 2003; 51: 1451-1454
        • Hurria A.
        • Gupta S.
        • Zauderer M.
        • et al.
        Developing a cancer-specific geriatric assessment: a feasibility study.
        Cancer. 2005; 104: 1998-2005
        • Folstein M.F.
        • Folstein S.E.
        • McHugh P.R.
        Mini-mental state". a practical method for grading the cognitive state of patients for the clinician.
        J Psychiatr Res. 1975; 12: 189-198
        • Nasreddine Z.S.
        • Phillips N.A.
        • Bedirian V.
        • et al.
        The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
        J Am Geriatr Soc. 2005; 53: 695-699
        • Cordell C.B.
        • Borson S.
        • Boustani M.
        • et al.
        Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the medicare annual wellness visit in a primary care setting.
        Alzheimers Dement. 2013; 9: 141-150
        • Maggiore R.J.
        • Gross C.P.
        • Hurria A.
        Polypharmacy in older adults with cancer.
        Oncologist. 2010; 15: 507-522
        • Sokol K.C.
        • Knudsen J.F.
        • Li M.M.
        Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
        J Clin Pharm Ther. 2007; 32: 169-175
        • Chen L.J.
        • Trares K.
        • Laetsch D.C.
        • et al.
        Systematic review and meta-analysis on the associations of polypharmacy and potentially inappropriate medication with adverse outcomes in older cancer patients.
        J Gerontol A Biol Sci Med Sci. 2021; 76: 1044-1052
        • Mohamed M.R.
        • Ramsdale E.
        • Loh K.P.
        • et al.
        Associations of polypharmacy and inappropriate medications with adverse outcomes in older adults with cancer: a systematic review and meta-analysis.
        Oncologist. 2020; 25: e94-e108
        • Feng X.
        • Higa G.M.
        • Safarudin F.
        • et al.
        Potentially inappropriate medication use and associated healthcare utilization and costs among older adults with colorectal, breast, and prostate cancers.
        J Geriatr Oncol. 2019; 10: 698-704
        • Karuturi M.S.
        • Holmes H.M.
        • Lei X.
        • et al.
        Potentially inappropriate medication use in older patients with breast and colorectal cancer.
        Cancer. 2018; 124: 3000-3007
        • Hakozaki T.
        • Hosomi Y.
        • Shimizu A.
        • et al.
        Polypharmacy as a prognostic factor in older patients with advanced non-small-cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapy.
        J Cancer Res Clin Oncol. 2020; 146: 2659-2668
        • Whitman A.
        • DeGregory K.
        • Morris A.
        • et al.
        Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
        Support Care Cancer. 2018; 26: 4105-4113
        • Hanlon J.T.
        • Schmader K.E.
        • Samsa G.P.
        • et al.
        A method for assessing drug therapy appropriateness.
        J Clin Epidemiol. 1992; 45: 1045-1051
        • Schmader K.
        • Hanlon J.T.
        • Weinberger M.
        • et al.
        Appropriateness of medication prescribing in ambulatory elderly patients.
        J Am Geriatr Soc. 1994; 42: 1241-1247
        • Miller M.G.
        • Kneuss T.G.
        • Patel J.N.
        • et al.
        Identifying potentially inappropriate medication (PIM) use in geriatric oncology.
        J Geriatr Oncol. 2021; 12: 34-40
        • O'Mahony D.
        • O'Sullivan D.
        • Byrne S.
        • et al.
        STOPP/START criteria for potentially inappropriate prescribing in older people: version 2.
        Age Ageing. 2015; 44: 213-218
        • Hamilton H.
        • Gallagher P.
        • Ryan C.
        • et al.
        Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients.
        Arch Intern Med. 2011; 171: 1013-1019
        • Gallagher P.
        • O'Mahony D.
        STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria.
        Age Ageing. 2008; 37: 673-679
        • Ramsdale E.
        • Lemelman T.
        • Loh K.P.
        • et al.
        Geriatric assessment-driven polypharmacy discussions between oncologists, older patients, and their caregivers.
        J Geriatr Oncol. 2018; 9: 534-539
        • Scott I.A.
        • Hilmer S.N.
        • Reeve E.
        • et al.
        Reducing inappropriate polypharmacy: the process of deprescribing.
        JAMA Intern Med. 2015; 175: 827-834
        • Canoui-Poitrine F.
        • Reinald N.
        • Laurent M.
        • et al.
        Geriatric assessment findings independently associated with clinical depression in 1092 older patients with cancer: the ELCAPA Cohort Study.
        Psychooncology. 2016; 25: 104-111
        • Butters M.A.
        • Whyte E.M.
        • Nebes R.D.
        • et al.
        The nature and determinants of neuropsychological functioning in late-life depression.
        Arch Gen Psychiatry. 2004; 61: 587-595
        • Christensen H.
        • Jorm A.F.
        • Mackinnon A.J.
        • et al.
        Age differences in depression and anxiety symptoms: a structural equation modelling analysis of data from a general population sample.
        Psychol Med. 1999; 29: 325-339
        • Gallo J.J.
        • Anthony J.C.
        • Muthen B.O.
        Age differences in the symptoms of depression: a latent trait analysis.
        J Gerontol. 1994; 49: P251-P264
        • Yesavage J.A.
        • Brink T.L.
        • Rose T.L.
        • et al.
        Development and validation of a geriatric depression screening scale: a preliminary report.
        J Psychiatr Res. 1982; 17: 37-49
        • Rinaldi P.
        • Mecocci P.
        • Benedetti C.
        • et al.
        Validation of the five-item geriatric depression scale in elderly subjects in three different settings.
        J Am Geriatr Soc. 2003; 51: 694-698
        • Hoyl M.T.
        • Alessi C.A.
        • Harker J.O.
        • et al.
        Development and testing of a five-item version of the geriatric depression scale.
        J Am Geriatr Soc. 1999; 47: 873-878
        • Manea L.
        • Gilbody S.
        • Hewitt C.
        • et al.
        Identifying depression with the PHQ-2: a diagnostic meta-analysis.
        J Affect Disord. 2016; 203: 382-395
        • Butler A.C.
        • Chapman J.E.
        • Forman E.M.
        • et al.
        The empirical status of cognitive-behavioral therapy: a review of meta-analyses.
        Clin Psychol Rev. 2006; 26: 17-31
        • Nezu A.M.
        • Nezu C.M.
        • Felgoise S.H.
        • et al.
        Project genesis: assessing the efficacy of problem-solving therapy for distressed adult cancer patients.
        J Consult Clin Psychol. 2003; 71: 1036-1048
      3. Evidence based practice guidelines for the nutritional management of malnutrition in adult patients across the continuum of care.
        Nutr Diet. 2009; 66: S1-S34
        • Pressoir M.
        • Desne S.
        • Berchery D.
        • et al.
        Prevalence, risk factors and clinical implications of malnutrition in French comprehensive cancer centres.
        Br J Cancer. 2010; 102: 966-971
        • Edwards B.J.
        • Zhang X.
        • Sun M.
        • et al.
        Overall survival in older patients with cancer.
        BMJ Support Palliat Care. 2020; 10: 25-35
        • Rasheed S.
        • Woods R.T.
        Malnutrition and quality of life in older people: a systematic review and meta-analysis.
        Ageing Res Rev. 2013; 12: 561-566
        • Izawa K.P.
        • Watanabe S.
        • Oka K.
        • et al.
        Differences in daily in-hospital physical activity and geriatric nutritional risk index in older cardiac inpatients: preliminary results.
        Aging Clin Exp Res. 2014; 26: 599-605
        • Versteeg K.S.
        • Konings I.R.
        • Lagaay A.M.
        • et al.
        Prediction of treatment-related toxicity and outcome with geriatric assessment in elderly patients with solid malignancies treated with chemotherapy: a systematic review.
        Ann Oncol. 2014; 25: 1914-1918
        • Neumayer L.A.
        • Smout R.J.
        • Horn H.G.
        • et al.
        Early and sufficient feeding reduces length of stay and charges in surgical patients.
        J Surg Res. 2001; 95: 73-77
        • Guigoz Y.
        • Lauque S.
        • Vellas B.J.
        Identifying the elderly at risk for malnutrition. the mini nutritional assessment.
        Clin Geriatr Med. 2002; 18: 737-757
        • Boleo-Tome C.
        • Monteiro-Grillo I.
        • Camilo M.
        • et al.
        Validation of the malnutrition universal screening tool (MUST) in cancer.
        Br J Nutr. 2012; 108: 343-348
        • Tomaka J.
        • Thompson S.
        • Palacios R.
        The relation of social isolation, loneliness, and social support to disease outcomes among the elderly.
        J Aging Health. 2006; 18: 359-384
        • Sherbourne C.D.
        • Stewart A.L.
        The MOS social support survey.
        Soc Sci Med. 1991; 32: 705-714
        • Dale W.
        • Williams G.R.
        • MscKenzie A.R.
        • et al.
        How is geriatric assessment used in clinical practice for older adults with cancer? a survey of cancer providers by the american society of clinical oncology.
        JCO Oncol Pract. 2021; 17: 336-344
        • Salazar M.
        • James D.
        • Welch C.
        • et al.
        Implementation of a geriatric oncology screening tool (G8) in an academic oncology practice serving a Hispanic-rich population.
        J Clin Oncol. 2019; 37: 87
        • Overcash J.A.
        • Beckstead J.
        • Extermann M.
        • et al.
        The abbreviated comprehensive geriatric assessment (aCGA): a retrospective analysis.
        Crit Rev Oncol Hematol. 2005; 54: 129-136
        • Bellera C.A.
        • Rainfray M.
        • Mathoulin-Pelissier S.
        • et al.
        Screening older cancer patients: first evaluation of the G-8 geriatric screening tool.
        Ann Oncol. 2012; 23: 2166-2172
        • Saliba D.
        • Elliott M.
        • Rubenstein L.Z.
        • et al.
        The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community.
        J Am Geriatr Soc. 2001; 49: 1691-1699
        • Hamaker M.E.
        • Jonker J.M.
        • de Rooij S.E.
        • et al.
        Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review.
        Lancet Oncol. 2012; 13: e437-e444
        • Soubeyran P.
        • Bellera C.
        • Goyard J.
        • et al.
        Screening for vulnerability in older cancer patients: the ONCODAGE prospective multicenter cohort study.
        PLoS One. 2014; 9: e115060
        • Martinez-Tapia C.
        • Canoui-Poitrine F.
        • Bastuji-Garin S.
        • et al.
        Optimizing the G8 screening tool for older patients with cancer: diagnostic performance and validation of a six-item version.
        Oncologist. 2016; 21: 188-195
        • Hurria A.
        • Togawa K.
        • Mohile S.G.
        • et al.
        Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.
        J Clin Oncol. 2011; 29: 3457-3465
        • Magnuson A.
        • Sedrak M.S.
        • Gross C.P.
        • et al.
        Development and validation of a risk tool for predicting severe toxicity in older adults receiving chemotherapy for early-stage breast cancer.
        J Clin Oncol. 2021; 39: 608-618